LYON, France--(BUSINESS WIRE)--Apr. 24, 2018-- Regulatory News: ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), the clinical-stage biopharmaceutical company developing innovative therapies for severe forms of cancer and orphan diseases ba
Read MoreArticle 223-16 of general regulation of French Autorité des Marchés Financiers LYON, France--(BUSINESS WIRE)--Apr. 16, 2018-- Regulatory News: Erytech (Euronext: ERYP- Nasdaq: ERYP): Listing markets: Euronext Paris from Eu
Read More